Immunogenicity of outer membrane proteins in a lipopolysaccharide- deficient mutant of Neisseria meningitidis: Influence of adjuvants on the immune response

Infection and Immunity

Volumn 67, Issue 10, 1999, Pages 4988-4993

  Steeghs, Liana ^a   Kuipers, Betsy ^a   Hamstra, Hendrik Jan ^a   Kersten, Gideon ^a   Van Alphen, Loek ^a   Van Der Ley, Peter ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIUM MUTANT; DRUG TOLERABILITY; ESCHERICHIA COLI; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; RHODOBACTER SPHAEROIDES; SERUM BACTERICIDAL ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION; THERMAL EXPOSURE;

EID: 0032858030     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.10.4988-4993.1999     Document Type: Article

References (44)

1. Abdillahi, H., and J. T. Poolman. 1987. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48: 367-371.
2. Andersen, S. R., G. Bjune, E. A. Hoiby, T. E. Michaelsen, A. Aase, U. Rye, and E. Jantzen. 1997. Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response. Vaccine 15:1225-1234.
3. Anderson, M. S., and C. R. H. Raetz. 1987. Biosynthesis of lipid A precursors in Escherichia coli. A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine. J. Biol. Chem. 262:5159-5169.
4. Bjune, G., E. A. Hoiby, J. K. Gronnesby, O. Arnesen, J. H. Frederiksen, A. Halstenen, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 348:1093-1096.
5. Coleman, J., and C. R. H. Raetz. 1988. First committed step of lipid A biosynthesis in Escherichia coli: sequence of the lpxA gene. J. Bacteriol. 170: 1268-1274.
6. Ey, P. L., G. J. Russell-Jones, and C. R. Jenkin. 1980. Isotypes of mouse IgG-I. Evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement. Mol. Immunol. 17:699-710.
7. Finne, J., D. Bitter-Suerman, C. Goridis, and U. Finne. 1987. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138:4402-4407.
8. Gotschlich, E. C. 1994. Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide. J. Exp. Med. 180:2181-2190.
9. Hoogerhout, P., E. M. L. M. Donders, J. A. M. van Gaans-van den Brink, B. Kuipers, H. F. Brugghe, L. M. A. van Unen, H. A. M. Timmermans, G. J. ten Hove, A. P. J. M. de Jong, C. A. M. Peeters, E. J. H. J. Wiertz, and J. T. Poolman. 1995. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis. Infect. Immun. 63:3473-3478.
10. Idänpään-Heikkilä, I., S. Muttilainen, E. Wahlström, L. Saarinen, M. Leinonen, M. Sarvas, and P. H. Mäkelä. 1995. The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis. Vaccine 13:1501-1508.
11. Idänpään-Heikkilä, I., E. Wahlström, S. Muttilainen, M. Nuriminen, H. Käyhty, M. Sarvas, and P. H. Mäkelä. 1996. Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100. Vaccine 14: 886-891.
12. Jennings, M. P., M. Bisercic, K. L. R. Dunn, M. Virji, A. Martin, K. E. Wilks, J. C. Richards, and E. R. Moxon. 1995. Cloning and molecular analysis of the lsil (rfaF) gene of Neisseria meningitidis which encodes a heptosyl-2-transferase involved in LPS biosynthesis: evaluation of surface exposed carbohydrates in LPS mediated toxicity for human endothelial cells. Microb. Pathog. 19:391-407.
13. Jennings, M. P., D. W. Hood, I. R. A. Peak, M. Virji, and E. R. Moxon. 1995. Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal LPS structure in Neisseria meningitidis. Mol. Microbiol. 18:729-740.
14. Jennings, M. P., P. van der Ley, K. E. Wilks, D. J. Maskell, J. T. Poolman, and E. R. Moxon. 1993. Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis. Mol. Microbiol. 10:361-369.
15. Johnson, A. G., G. Gaines, and M. Landy. 1956. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J. Exp. Med. 103:225.
16. Johnson, A. G. 1994. Molecular adjuvants and immunomodulators: new approaches to immunization. Clin. Microbiol. Rev. 7:277-289.
17. Jones, B. D., W. A. Nichols, B. W. Gibson, M. G. Sunshine, and M. A. Apicella. 1997. Study of the role of the htrB gene in Salmonella typhimurium virulence. Infect. Immun. 65:4778-4783.
18. Kenney, J. S., B. W. Hughes, M. P. Masada, and A. C. Allison. 1989. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murinc antibodies. J. Immunol. Methods 121:157-166.
19. Kersten, G. 3990. Aspects of Iscoms. Structural, pharmaceutical and adjuvant properties. Ph.D. thesis. University of Utrecht, Utrecht, The Netherlands.
20. Mandrell, R. E., J. McLeod Griffiss, and B. A. Macher. 1988. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunchemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize cross-reacting antigens on LOS and human erythrocytes. J. Exp. Med. 168:107-126.
21. Munford, R. S., A. L. Erwin, F. X. Riedo, and C. L. Hall. 1990. Lipopolysaccharide signal modification by acyloxyaxylhydrolase, a leukocyte enzyme, p. 271-282. In E. M. Ayoub, G. H. Cassell, W. C. Branche, and T. J. Henry (ed.), Microbial determinants of virulence and host response 1990. American Society for Microbiology, Washington, D.C.
22. Myers, K. R., A. T. Truchot, J. Word, Y. Hudson, and J. T. Ulrich. 1990. A critical determinant of lipid A endotoxic activity, p. 145-156. In A. Nowotny, J. J. Spitzer, and E. J. Ziegler (ed.), Cellular and molecular aspects of endotoxin reactions. Elsevier Science Publishing Co., New York, N.Y.
23. Nichols, W. A., C. R. H. Raetz, T. Clementz, A. L. Smith, J. A. Hanson, M. R. Ketterer, M. Sunshine, and M. A. Apicella. 1997. htrB of Haemophilus influenzae: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity. J. Endotoxin Res. 4:163-172.
24. O'Hagan, D. T., G. S. Ott, and G. van Nest. 1997. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. Mol. Med. Today 3:69-75.
25. Osborn, M. J. 1963. Studies on the Gram-negative cell wall. I. Evidence for the role of 2-keto-3-deoxyoctonoate in the lipopolysaccharide of Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 50:499-506.
26. Petrov, A. B., V. M. Kolenko, N. V. Koshkina, M. M. Zakirov, L. V. Bugaeb, I. B. Semenova, E. J. H. J. Wiertz, and J. T. Poolman. 1994, Non-specific modulation of the immune response with liposomal meningococcal lipopolysaccharide: role of different cells and cytokines. Vaccine 12:1064-1070.
27. Sandlin, R. C., R. J. Danaher, and D. C. Stein. 1994. Genetic basis of pyocin resistance in Neisseria gonorrhoeae. J. Bacteriol. 176:6869-6876.
28. Steeghs, L., R. den Hartog, A. den Boer, B. Zomer, P. Roholl, and P. van der Ley. 1998. Meningitis bacterium is viable without endotoxin. Nature 392: 449-450.
29. Steeghs, L., M. P. Jennings, J. T. Poolman, and P. van der Ley. 1997. Isolation and characterization of the Neisseria meningitidis lpxD-fabZ-lpxA gene cluster involved in lipid A biosynthesis. Gene 190:263-270.
30. Stojiljkovic, I., V. Hwa, J. Larson, L. Lin, M. So, X. Nassif. 1997. Cloning and characterization of the Neisseria meningitidis rfaC gene encoding α-1,5 heptosyltransferase I. FEMS Microbiol. Lett. 151:41-49.
31. Saukkonen, K., H. Abdillahi, J. T. Poolman, and M. Leinonen. 1987. Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningilidis B15:P1.16 in an infant rat infection model: new prospects for vaccine development. Microb. Pathog. 3:261-267.
32. Takada, H., and S. Kotani. 1989. Structural requirements of lipid A for endotoxicity and other biological activities. Crit. Rev. Microbiol. 16:477-523.
33. van der Ley, P., J. E. Heckels, M. Virji, P. Hoogerhout, and J. T. Poolman. 1991. Tolpology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:2963-2971.
34. van der Ley, P., M. Kramer, A. Martin, J. C. Richards, and J. T. Poolman. 1997. Analysis of the icsBA locus for biosynthesis of the inner core region from Neisseria meningitidis lipopolysaccharide. FEMS Microbiol. Lett. 146: 247-253.
35. van der Ley, P., J. van der Biezen, P. Hohenstein, C. Peeters, and J. T. Poolman. 1993. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis. Infect. Immun. 61:4217-4224.
36. van der Ley, P., J. van der Biezen, and J. T. Poolman. 1995. Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine 13:401-407.
37. van der Ley, P., et al. Unpublished data.
38. Verheul, A. F. M., H. Snippe, and J. T. Poolman. 1993. Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol. Rev. 57:34-49.
39. Verheul, A. F. M., J. A. M. van Gaans, E. J. H. Wiertz, H. Snippe, J. Verhoef, and J. T. Poolman. 1993. Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein-but not LPS-specific bactericidal antibodies in mice: Influence of adjuvants. Infect. Immun. 61:187-196.
40. Virji, M., J. N. Weiser, A. A. Lindberg, and E. R. Moxon. 1990. Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of an oligosaccharide structure also present on human cells. Microb. Pathog. 9:441.
41. Ward, S. J., D. Scopes, M. Christodoulides, I. N. Clarke, and J. E. Heckels. 1996. Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: the influence of liposomes and adjuvants on the production of a bactericidal immune response. Microb. Pathog. 21:499-512.
42. Westphal, O., and J. K. Jann. 1965. Bacterial lipopolysaccharide extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem. 5:83-91.
43. Zhou, D., D. S. Stephens, B. W. Gibson. J. J. Engstrom, C. F. McAllister, F. K. N. Lee, and M. A. Apicella. 1994. Lipooligosaccharide biosynthesis in pathogenic Neisseria. Cloning, identification and characterization of the phosphoglucomutase gene. J. Biol. Chem. 269:11162-11169.
44. Zollinger, W. D. 1990. New and improved vaccines against meningococcal disease, p. 325-348. In G. C. Woodrow and M. M. Levine (ed.), New generation vaccines. Marcel Dekker Inc., New York, N.Y.